Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Biotech
Neurogene stops Batten gene therapy after FDA denies request
Neurogene followed up a premarket setback to its Rett syndrome program Monday with a postmarket confirmation that development of another gene therapy has hit a wall.
Nick Paul Taylor
Nov 19, 2024 6:30am
Regenxbio starts pivotal study for DMD gene therapy
Nov 18, 2024 2:24pm
Gene therapy reduces harmful protein levels in mouse kidneys
Oct 29, 2024 12:54pm
GenSight enters final weeks of cash runway
Oct 25, 2024 3:19am
Poseida gene therapy reduces kallikrein protein levels in mice
Oct 24, 2024 1:20pm
Roche bets up to $1B to expand Dyno gene therapy delivery pact
Oct 24, 2024 10:40am
